Correlation Between Agios Pharm and Prometheus Biosciences
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Prometheus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Prometheus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Prometheus Biosciences, you can compare the effects of market volatilities on Agios Pharm and Prometheus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Prometheus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Prometheus Biosciences.
Diversification Opportunities for Agios Pharm and Prometheus Biosciences
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Agios and Prometheus is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Prometheus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prometheus Biosciences and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Prometheus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prometheus Biosciences has no effect on the direction of Agios Pharm i.e., Agios Pharm and Prometheus Biosciences go up and down completely randomly.
Pair Corralation between Agios Pharm and Prometheus Biosciences
If you would invest 19,992 in Prometheus Biosciences on September 20, 2024 and sell it today you would earn a total of 0.00 from holding Prometheus Biosciences or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 1.59% |
Values | Daily Returns |
Agios Pharm vs. Prometheus Biosciences
Performance |
Timeline |
Agios Pharm |
Prometheus Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Agios Pharm and Prometheus Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Agios Pharm and Prometheus Biosciences
The main advantage of trading using opposite Agios Pharm and Prometheus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Prometheus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prometheus Biosciences will offset losses from the drop in Prometheus Biosciences' long position.Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
Prometheus Biosciences vs. Apellis Pharmaceuticals | Prometheus Biosciences vs. Akero Therapeutics | Prometheus Biosciences vs. Immunovant | Prometheus Biosciences vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Global Correlations Find global opportunities by holding instruments from different markets |